Bio Rad Laboratories Inc
Health Care
Current price
Target price 00%
Ranks rating
76
Position in sub-industry
139 / 240
Position in country
10174 / 14179
Return on Assets, %
-4.8
-2.7
Net income margin, %
51.3
-6.7
EBITDA margin, %
20.3
5.6
Debt to Equity, %
13.7
15.1
Intangible assets and goodwill, %
5.9
4.7
Revenue CAGR 3Y, %
1.6
12.8
Total Equity change 1Y, %
-9.1
-2.4
Revenue Y, % chg
-4.7
0
P/BV
0.9
2
P/S
3.7
4.1
EV/S
3.7
3.6
EV/EBITDA
19.1
7.8
Average Analyst recommendation
Hold
Hold
Average upside forecasts, %
39.7
48.9
Forward P/E
27.4
25.5
Expected dividend per share
0
0
Competitors
Ranks
-
IQVIA Holdings Inc
00%
-
West Pharmaceutical Services Inc
00%
-
Agilent Technologies Inc
00%
-
Avantor Inc
00%
-
Thermo Fisher Scientific Inc
00%
-
Danaher Corp
00%
-
Waters Corp
00%
-
Bio Rad Laboratories Inc
00%
-
Mettler-Toledo International Inc
00%
-
Illumina Inc
00%
Ready-made portfolio of the best Russian stocks
- Created by artificial intelligence
- Verified by analysts
- Available even to beginners
Company information
Country
United States of America
Sector
Health Care
Industry group
Pharmaceuticals, Biotechnology & Life Sciences
Industry
Life Sciences Tools & Services
Sub-sector
Health Care
Capitalization (millions of $)
10293.5
Ticker
BIO.N
ISIN
US0905722072
IPO date
1980-03-17
Availability on Russian exchanges
Yes
Reporting for
2024-02-16
Date fact. publication of reports
2023-12-31
Company Description
Bio-Rad Laboratories, Inc. manufactures and supplies the life science research, healthcare, analytical chemistry and other markets with a range of products and systems used to separate chemical and biological materials and to identify, analyze and purify their components. The Company operates through two segments: Life Science and Clinical Diagnostics. Life Science segment markets and develops, manufactures and markets approximately 6,000 reagents, apparatus and laboratory instruments. Its products are used in research techniques, biopharmaceutical production processes and food testing regimes. Clinical Diagnostics segment designs, manufactures, sells and supports test systems, informatics systems, test kits and specialized quality controls that serve clinical laboratories in the global diagnostics market.
A step towards better analytics
- find the best promotions through the Screener
- keep an eye on stock valuation
- download detailed reports
and much more after free registration
RegistrationMore convenient from your phone? Download: